Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.505 SEK | -2.70% |
|
+1.00% | +10.62% |
Jul. 01 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
May. 22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |